Key Highlights

  • Profusa shareholders approved a 1-for-25 reverse stock split, reducing outstanding shares from approximately 13.2 million.
  • The split takes effect shortly after market close, with trading resuming under the same ticker symbol PFSA.
  • Authorized shares remain at 601 million, while par value stays unchanged at $0.0001 per share.
  • Equity incentives, including stock options and warrants, will adjust proportionally to reflect the new share count.

Split Ratio Confirmed

Profusa (NASDAQ: PFSA) has finalized its plans for a 1-for-25 reverse stock split after receiving shareholder approval during its annual meeting. The board authorized the CEO to determine the consolidation ratio, opting for 25 shares to be combined into one. This decision aligns with the company’s efforts to comply with Nasdaq’s minimum bid price requirements while maintaining market liquidity.

Effective Date Set

The reverse stock split will take effect shortly after the market closes on the designated date. Trading on the Nasdaq Capital Market will resume the following day under the existing ticker symbol PFSA, though with an updated CUSIP identifier. Shareholders holding positions at the close of the prior trading session will see their holdings adjusted automatically to reflect the consolidation.

Share Count Adjustments

Following the split, Profusa’s common stock outstanding will be reduced from approximately 13.2 million shares. The company’s authorized shares will remain at 601 million, preserving flexibility for future equity issuance. The par value of $0.0001 per share will stay unchanged, ensuring the stock’s nominal structure remains intact.

Equity Incentive Impact

All existing stock options, restricted stock units, and warrants will be adjusted proportionally to account for the 1-for-25 ratio. Exercise prices for options and warrants will increase accordingly, while the number of shares issuable under these instruments will decrease. The company’s equity incentive plan will also see a proportional reduction in the number of reserved shares.

Fractional Share Treatment

No fractional shares will result from the consolidation. Instead, Profusa will provide cash payments to shareholders for any fractional amounts, based on the closing price of the stock on the effective date. This approach ensures all investors receive whole shares or their equivalent value, eliminating partial holdings.

Financial Reporting Effects

The reverse stock split will require retroactive adjustments to per-share metrics in financial statements for prior reporting periods. Basic and diluted net loss per share will be recalculated to reflect the reduced share count, allowing investors to maintain comparability across financial disclosures.

Regulatory Compliance

Profusa has filed the necessary amendment to its certificate of incorporation with Delaware’s Secretary of State, fulfilling all legal requirements. The company’s disclosures adhere to the Securities Exchange Act of 1934, ensuring transparency for shareholders and market participants. The move reflects broader trends in the healthcare sector, where smaller companies often use reverse splits to maintain exchange compliance and attract institutional interest.

FAQs

This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making investment decisions.